RGCB study reveals host biology influences malaria treatment failures, suggesting new strategies to enhance drug efficacy and reduce relapses.

RGCB scientists discover how malaria parasites exploit young blood cells to resist artemisinin, challenging traditional views on drug resistance.

RGCB study reveals host biology influences malaria treatment failures, suggesting new strategies to enhance drug efficacy and reduce relapses.